News

2025 Oct 03

Study Finds Restoring Order to Dividing Cancer Cells May Prevent Metastasis

Triple negative breast cancer (TNBC) is one of the most aggressive and hardest to treat breast cancers, but a new study led by Weill Cornell Medicine suggests a way to stop it from spreading. Researchers have discovered that... Read more

2025 Aug 14

Two Weill Cornell Medicine Scientists Selected for 2025 Pew Awards

Weill Cornell Medicine faculty member Dr. Anna Nam and postdoctoral fellow Dr. Maria Cecilia Lira have been chosen to join the 2025 class of Pew scholars and fellows. Dr. Nam, an assistant professor of pathology and... Read more

2025 Aug 11

What’s Melanoma? A Primer on This Dangerous Skin Cancer

Skin cancer is the most common type of cancer in America. Melanoma skin cancer is the least common type, making up only 1 out of 100 skin cancers, according to the American Cancer Society . If it’s so rare, what’s the big... Read more

2025 Aug 11

Laura Pinheiro, PhD, MPH, Appointed to Co-Lead Community Outreach and Engagement at the Sandra and Edward Meyer Cancer Center

The Sandra and Edward Meyer Cancer Center (MCC) of Weill Cornell Medicine and NewYork - Presbyterian Hospital has appointed Laura Pinheiro, PhD, MPH to join Erica Phillips, MD in co-leading the Center’s Office of Community... Read more

2025 Jul 31

Not All Low-Grade Prostate Cancers Are Low Risk

A new study reveals that some men who are diagnosed with “Grade Group one” (GG1) prostate cancer may actually be at higher risk than biopsy results suggest, according to research led by Weill Cornell Medicine, University... Read more

2025 Jul 29

Uncovering How a Molecule Responsible for Immune “Brakes” Directs Skin Defenses

Weill Cornell Medicine researchers have discovered that PD-1—a molecule best known for putting the brakes on immune cells—also plays a critical role in helping T cells become long-term immune defenders in the skin. Early... Read more

2025 Jul 17

Study Reveals New Clues in Liver Disease Prevention

The aging liver undergoes dramatic changes in its functional organization and other key attributes, which may underpin its increasing susceptibility to disease, according to a study led by investigators at Weill Cornell... Read more

Participants in the Empire State Cellular Therapy Consortium in February 2025 at Roswell Park Comprehensive Cancer Center, Buffalo, NY.

2025 Jul 10

Research Leaders Across New York State Form Empire State Cellular Therapy Consortium

Experts in newest treatment option for cancer, neurological disorders unite to speed progress, expand access Consortium members will share resources, collaborate on clinical trials Statewide experts look to expand benefits... Read more

2025 Jul 07

New Precision Medicine Approach Identifies a Promising Ovarian Cancer Treatment

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to a preclinical study led by Weill Cornell Medicine investigators. The research reveals a promising... Read more

woman pointing at a computer screen while another woman looks on

2025 Jun 24

Research at Risk: Stopping Metastatic Cancer

Video of Research at Risk: Stopping metastatic cancer Metastasis. It’s the word cancer patients dread most – and the scan with ominous black spots showing the disease has spread. For too many people, metastatic cancer is... Read more

A man in a suit giving a presentation at a podium

2025 Jun 03

Dr. Nikolaos Koundouros Wins 2025 Tri-Institutional Breakout Award

Dr. Nikolaos Koundouros , a postdoctoral associate in the Department of Pharmacology at Weill Cornell Medicine, has been awarded a 2025 Tri-Institutional Breakout Award for Junior Investigators. Weill Cornell Medicine,... Read more

researcher holding a vial of blood over a rack of vials

2025 Jun 02

Switch to Experimental Drug after Liquid Biopsy Detection of Breast Cancer Recurrence Improves Outcomes

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid biopsy blood tests for early detection of a treatment-resistance mutation, followed by a switch to a new... Read more

2025 May 29

New Insights into Bladder Cancer Treatment Could Help Improve Immunotherapies

Bacillus Calmette-Guerin (BCG) vaccine. Courtesy of Memorial Sloan Kettering Cancer Center. More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first... Read more

blue spherical objects against a black backdrop

2025 May 29

Two WCM Scientists Receive Inaugural Pershing Square Foundation Ovarian Cancer Challenge Grant

Dr. Juan R. Cubillos-Ruiz , the William J. Ledger, M.D. Distinguished Associate Professor of Infection and Immunology in Obstetrics and Gynecology, and Dr. David Lyden , the Stavros S. Niarchos Professor in Pediatric... Read more

2025 May 22

Ritu Banga Healthcare Disparities Research Awards Support Innovative Science

Four Weill Cornell Medicine investigators received the Ritu Banga Healthcare Disparities Research Awards, recognizing innovative research that will help close care gaps in clinical settings. Endowed through a generous $5... Read more

2025 May 09

National Cancer Institute Grant Funds Prostate Cancer Imaging Study

Weill Cornell Medicine has received a projected $4 million grant from the National Cancer Institute, part of the National Institutes of Health, to conduct a clinical trial testing whether a new imaging approach could reduce... Read more

2025 May 05

How a Tiny RNA Modification Helps Control Cell Stress Responses

A tiny chemical modification commonly found on messenger RNAs plays a surprisingly large role in how cells respond to stress, according to a study led by Weill Cornell Medicine investigators. The finding clarifies an... Read more

2025 Apr 21

Three-Dimensional Gene Hubs May Promote Brain Cancer

The way DNA folds inside the nucleus of brain cells may hold the key to understanding a devastating form of brain cancer called glioblastoma, suggests a new preclinical study from Weill Cornell Medicine researchers. The... Read more

2025 Apr 16

Study Finds Protein Partnership Protects Chromosomes

A new study from Weill Cornell Medicine provides insights into how cells maintain the tiny end caps of chromosomes as they divide, a key process in keeping cells healthy. Using yeast, the researchers reveal protein... Read more

Cartoon image of green figures blocking blue figures from accessing a castle turret with cancer cells

2025 Apr 15

Gut Microbes Release Cancer-fighting Bile Acids that Block Hormone Signals

Bacteria naturally present in the human intestine, known as the gut microbiota, can transform cholesterol-derived bile acids into powerful metabolites that strengthen anti-cancer immunity by blocking androgen signaling,... Read more